TABLE OF CONTENTS
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET: GEOGRAPHICAL SCOPE
2.3 YEAR CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 VENDOR SHARE ANALYSIS
2.10 MULTIVARIATE MODELING
2.11 TIMELINE CURVE
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 INCREASING PREVALENCE OF DIABETES
3.1.2 INCREASING OBESITY
3.1.3 RISING NUMBER OF GERIATRIC POPULATION
3.1.4 HIGH ACCEPTANCE OF SOFTWARE APPLICATIONS RELATED TO DIABETES
3.2 RESTRAINTS
3.2.1 RECALL OF DEVICES
3.2.2 HIGH COST OF DEVICES
3.2.3 RIGID REIMBURSEMENT POLICY
3.2.4 TIME CONSUMING PRODUCT APPROVAL
3.3 OPPORTUNITIES
3.3.1 TECHNOLOGICAL INNOVATION
3.3.2 COLLABORATION AND PARTNERSHIP
3.3.3 EMERGING COUNTRY
3.4 CHALLENGES
3.4.1 TECHNOLOGY COMPETTION
3.4.2 STRINGENT REGULATION
3.4.3 LACK OF AWARENESS
4 REGULATORY PROCEDURE
4.1 PROCEDURE
4.2 REGULATION IN EUROPE
4.3 REGULATION IN REST OF THE WORLD
4.3.1 JAPAN
4.3.2 CHINA
4.3.3 INDIA
5 EXECUTIVE SUMMARY
6 PREMIUM INSIGHTS
7 INDUSTRY INSIGHT
8 NORTH AMERICA DIGITAL DIABETES MANAGEMNET MARKET, BY PRODUCT & SERVICES
8.1 OVERVIEW
8.2 DEVICES
8.2.1 CONTINUOUS GLUCOSE MONITORING SYSTEMS
8.2.2 SMART GLUCOSE METERS
8.2.3 SMART INSULIN PENS
8.2.4 SMART INSULIN PUMPS
8.3 DIGITAL DIABETES MANAGEMENT APPS
8.3.1 WEIGHT & DIET MANAGEMENT APPS
8.3.2 DIABETES & BLOOD GLUCOSE TRACKING APPS
8.4 DATA MANAGEMENT SOFTWARE AND PLATFORMS
8.5 SERVICES
9 NORTH AMERICA DIGITAL DIABETES MANAGEMNET MARKET, BY TYPE
9.1 OVERVIEW
9.2 HANDHELD DEVICES
9.3 WEARABLE DEVICES
10 NORTH AMERICA DIGITAL DIABETES MANAGEMNET MARKET, BY END USER
10.1 OVERVIEW
10.2 HOME CARE SETTINGS
10.3 DIABETES CLINICS
10.4 ACADEMIC & RESEARCH INSTITUTES
10.5 OTHERS
11 NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET, BY GEOGRAPHY
11.1 NORTH AMERICA
11.1.1 U.S.
11.1.2 CANADA
11.1.3 MEXICO
12 NORTH AMERICA DIGITAL DIABETES MANAGEMENT MARKET, COMPANY LANDSCAPE
12.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
13 COMPANY PROFILES
13.1 F. HOFFMANN-LA ROCHE LTD
13.1.1 COMPANY SNAPSHOT
13.1.2 SWOT ANALYSIS
13.1.3 REVENUE ANALYSIS
13.1.4 COMPANY SHARE ANALYSIS
13.1.5 GEOGRAPHICAL PRESENCE
13.1.6 PRODUCT PORTFOLIO
13.1.7 RECENT DEVELOPMENTS
13.1.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.2 MEDTRONIC
13.2.1 COMPANY SNAPSHOT
13.2.2 SWOT ANALYSIS
13.2.3 REVENUE ANALYSIS
13.2.4 COMPANY SHARE ANALYSIS
13.2.5 GEOGRAPHICAL PRESENCE
13.2.6 PRODUCT PORTFOLIO
13.2.7 RECENT DEVELOPMENTS
13.2.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.3 NOVO NORDISK A/S
13.3.1 COMPANY SNAPSHOT
13.3.2 SWOT ANALYSIS
13.3.3 REVENUE ANALYSIS
13.3.4 COMPANY SHARE ANALYSIS
13.3.5 GEOGRAPHICAL PRESENCE
13.3.6 PRODUCT PORTFOLIO
13.3.7 RECENT DEVELOPMENTS
13.3.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
?
13.4 ABBOTT
13.4.1 COMPANY SNAPSHOT
13.4.2 SWOT ANALYSIS
13.4.3 REVENUE ANALYSIS
13.4.4 COMPANY SHARE ANALYSIS
13.4.5 GEOGRAPHICAL PRESENCE
13.4.6 PRODUCT PORTFOLIO
13.4.7 RECENT DEVELOPMENTS
13.4.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.5 DEXCOM, INC
13.5.1 COMPANY SNAPSHOT
13.5.2 SWOT ANALYSIS
13.5.3 REVENUE ANALYSIS
13.5.4 COMPANY SHARE ANALYSIS
13.5.5 GEOGRAPHICAL PRESENCE
13.5.6 PRODUCT PORTFOLIO
13.5.7 RECENT DEVELOPMENTS
13.5.8 DATA BRIDGE MARKET RESEARCH ANALYSIS
13.6 AGAMATRIX, INC
13.6.1 COMPANY SNAPSHOT
13.6.2 GEOGRAPHICAL PRESENCE
13.6.3 PRODUCT PORTFOLIO
13.6.4 RECENT DEVELOPMENTS
13.7 AZUMIO
13.7.1 COMPANY SNAPSHOT
13.7.2 GEOGRAPHICAL PRESENCE
13.7.3 PRODUCT PORTFOLIO
13.7.4 RECENT DEVELOPMENTS
13.8 B. BRAUN MELSUNGEN AG
13.8.1 COMPANY SNAPSHOT
13.8.2 REVENUE ANALYSIS
13.8.3 GEOGRAPHICAL PRESENCE
13.8.4 PRODUCT PORTFOLIO
13.8.5 RECENT DEVELOPMENTS
13.9 BD
13.9.1 COMPANY SNAPSHOT
13.9.2 REVENUE ANALYSIS
13.9.3 GEOGRAPHICAL PRESENCE
13.9.4 PRODUCT PORTFOLIO
13.9.5 RECENT DEVELOPMENTS
13.10 DARIO HEALTH
13.10.1 COMPANY SNAPSHOT
13.10.2 REVENUE ANALYSIS
13.10.3 GEOGRAPHICAL PRESENCE
13.10.4 PRODUCT PORTFOLIO
13.10.5 RECENT DEVELOPMENTS
13.11 DIABNEXT
13.11.1 COMPANY SNAPSHOT
13.11.2 GEOGRAPHICAL PRESENCE
13.11.3 PRODUCT PORTFOLIO
13.11.4 RECENT DEVELOPMENTS
13.12 GLOOKO, INC
13.12.1 COMPANY SNAPSHOT
13.12.2 PRODUCT PORTFOLIO
13.12.3 RECENT DEVELOPMENTS
13.13 GLUCOME
13.13.1 COMPANY SNAPSHOT
13.13.2 PRODUCT PORTFOLIO
13.13.3 RECENT DEVELOPMENTS
13.14 INSULET CORPORATION
13.14.1 COMPANY SNAPSHOT
13.14.2 REVENUE ANALYSIS
13.14.3 GEOGRAPHICAL PRESENCE
13.14.4 PRODUCT PORTFOLIO
13.14.5 RECENT DEVELOPMENTS
13.15 LIFESCAN, INC
13.15.1 COMPANY SNAPSHOT
13.15.2 GEOGRAPHICAL PRESENCE
13.15.3 PRODUCT PORTFOLIO
13.15.4 RECENT DEVELOPMENTS
13.16 PHC HOLDINGS CORPORATION
13.16.1 COMPANY SNAPSHOT
13.16.2 GEOGRAPHICAL PRESENCE
13.16.3 PRODUCT PORTFOLIO
13.16.4 RECENT DEVELOPMENTS
13.17 SANOFI
13.17.1 COMPANY SNAPSHOT
13.17.2 REVENUE ANALYSIS
13.17.3 GEOGRAPHICAL PRESENCE
13.17.4 PRODUCT PORTFOLIO
13.17.5 RECENT DEVELOPMENTS
13.18 SMART METER LLC
13.18.1 COMPANY SNAPSHOT
13.18.2 PRODUCT PORTFOLIO
13.18.3 RECENT DEVELOPMENTS
13.19 TANDEM DIABETES CARE
13.19.1 COMPANY SNAPSHOT
13.19.2 REVENUE ANALYSIS
13.19.3 GEOGRAPHICAL PRESENCE
13.19.4 PRODUCT PORTFOLIO
13.19.5 RECENT DEVELOPMENTS
13.20 VOLUNTIS
13.20.1 COMPANY SNAPSHOT
13.20.2 GEOGRAPHICAL PRESENCE
13.20.3 PRODUCT PORTFOLIO
13.20.4 RECENT DEVELOPMENTS
14 CONCLUSION
15 QUESTIONNAIRE
16 RELATED REPORTS
?